Literature DB >> 29054902

Chylous ascites in a patient with an overlap syndrome: a surprising response to rituximab.

Alexandra Daniel1, Gianluca Bagnato2, Edward Vital2, Francesco Del Galdo3.   

Abstract

The authors present a case of a 51-year-old woman with clinical diagnosis of mixed connective tissue disease and overlap systemic lupus erythematosus features, with a 6-month history of progressive painless abdominal distension. On examination, evident signs of ascites were present. Both the abdominal-pelvic ultrasound and CT scan confirmed a large amount of ascites. A diagnostic paracentesis was performed, which revealed typical features of chylous ascites (CA). An extensive diagnostic work-up led by a multidisciplinary team was performed, excluding malignancy, cirrhosis, infectious, as well as cardiac and primary lymphatic causes. The patient was kept under surveillance, with dietary therapy and periodic ascitic drainages. The hypothesis of an autoimmune cause for CA was considered by exclusion. Rituximab therapy was initiated and an excellent response was achieved, with reduction of the rate of accumulation of CA and an increase in quality of life of the patient. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  biological agents; connective tissue disease; gastrointestinal system

Mesh:

Substances:

Year:  2017        PMID: 29054902      PMCID: PMC5665331          DOI: 10.1136/bcr-2017-222339

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

Review 1.  Chylous ascites.

Authors:  Andrés Cárdenas; Sanjiv Chopra
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

2.  Massive ascites as a presenting feature of lupus.

Authors:  Shiva Prasad; Bonnie Abujam; Able Lawrence; Amita Aggarwal
Journal:  Int J Rheum Dis       Date:  2012-02       Impact factor: 2.454

Review 3.  Atraumatic chylous ascites: systematic review on symptoms and causes.

Authors:  Daniel C Steinemann; Daniel Dindo; Pierre-Alain Clavien; Antonio Nocito
Journal:  J Am Coll Surg       Date:  2011-03-12       Impact factor: 6.113

Review 4.  Chronic lupus peritonitis with ascites: review of the literature with a case report.

Authors:  J T Schousboe; A E Koch; R W Chang
Journal:  Semin Arthritis Rheum       Date:  1988-11       Impact factor: 5.532

5.  The role of laparoscopy in the evaluation of ascites of unknown origin.

Authors:  C M Chu; S M Lin; S M Peng; C S Wu; Y F Liaw
Journal:  Gastrointest Endosc       Date:  1994 May-Jun       Impact factor: 9.427

6.  Chronic lupus peritonitis with ascites.

Authors:  P Kaklamanis; G Vayopoulos; G Stamatelos; G Dadinas; G C Tsokos
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

7.  Diagnosis and management of primary chylous ascites.

Authors:  Corradino Campisi; Carlo Bellini; Costantino Eretta; Angelo Zilli; Elisa da Rin; Doris Davini; Eugenio Bonioli; Francesco Boccardo
Journal:  J Vasc Surg       Date:  2006-06       Impact factor: 4.268

8.  Chylous ascites and chylothorax as presentation of a systemic progression of discoid lupus.

Authors:  Diego Jorge Manzella; Pablo Nicolás Dettori; Mariano Luis Hertimian; Marcelo José Melero
Journal:  J Clin Rheumatol       Date:  2013-03       Impact factor: 3.517

9.  Chylous ascites and pleural transudate: rare presentations in systemic lupus erythematosus in old age.

Authors:  Guan-Liang Chen; Deng-Ho Yang; Wen-Hsiu Hsu
Journal:  Case Reports Immunol       Date:  2012-03-26

Review 10.  Chylous Ascites: Evaluation and Management.

Authors:  Said A Al-Busafi; Peter Ghali; Marc Deschênes; Philip Wong
Journal:  ISRN Hepatol       Date:  2014-02-03
View more
  1 in total

Review 1.  Lymphatic Function in Autoimmune Diseases.

Authors:  Noa Schwartz; Madhavi Latha S Chalasani; Thomas M Li; Zhonghui Feng; William D Shipman; Theresa T Lu
Journal:  Front Immunol       Date:  2019-03-20       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.